Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends Roche’s breast cancer drug pertuzumab

pharmaceutical-technologyFebruary 19, 2019

Tag: NICE , Roche , Breast Cancer , Pertuzumab

PharmaSources Customer Service